Drugs that contain Ezetimibe

1. List of Zetia drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7030106 ORGANON Sterol absorption inhibitor compositions
Jan, 2022

(1 year, 15 days ago)

US7030106

(Pediatric)

ORGANON Sterol absorption inhibitor compositions
Jul, 2022

(6 months ago)

US7612058 ORGANON Methods for inhibiting sterol absorption
Oct, 2025

(2 years from now)

US7612058

(Pediatric)

ORGANON Methods for inhibiting sterol absorption
Apr, 2026

(3 years from now)

Market Authorisation Date: 25 October, 2002

Treatment: To reduce elevated total-c, ldl-c, apo b and non-hdl-c in patients with primary hyperlipidemia by administration of ezetimibe alone or in combination with a statin or with fenofibrate; Reduction of elevated plasma sterol and/or stanol levels in a mammal

Dosage: TABLET;ORAL

How can I launch a generic of ZETIA before it's patent expiration?
More Information on Dosage

ZETIA family patents

37

United States

17

European Union

12

Japan

9

Australia

9

Canada

8

Austria

8

Hong Kong

8

Spain

8

Germany

8

Slovenia

8

Argentina

8

Portugal

8

China

8

Denmark

7

Mexico

6

Korea, Republic of

6

Cyprus

6

Hungary

6

Norway

6

Ecuador

5

Brazil

5

Slovakia

5

South Africa

5

Russia

5

Czech Republic

5

New Zealand

4

Poland

4

Taiwan, Province of China

2

Israel

1

Morocco

1

RS

1

Chile

1

Malaysia

1

Yugoslavia

1

Georgia

1

Peru

1

ME

1

Turkey

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic